Connor, Clark & Lunn Investment Management Ltd. Illumina, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Illumina, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 125,126 shares of ILMN stock, worth $17.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
125,126
Previous 10,660 1073.79%
Holding current value
$17.9 Million
Previous $1.11 Million 1367.27%
% of portfolio
0.09%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$105.28 - $135.9 $12.1 Million - $15.6 Million
114,466 Added 1073.79%
125,126 $16.3 Million
Q2 2024

Aug 09, 2024
BUY
$101.05 - $133.57 $1.08 Million - $1.42 Million
10,660 New
10,660 $1.11 Million
Q4 2023

Feb 09, 2024
BUY
$92.79 - $142.53 $12.1 Million - $18.6 Million
130,711 New
130,711 $18.2 Million
Q2 2023

Aug 10, 2023
SELL
$183.43 - $232.67 $19.1 Million - $24.2 Million
-104,009 Reduced 78.01%
29,319 $5.5 Million
Q1 2023

May 09, 2023
BUY
$193.75 - $232.55 $4.18 Million - $5.01 Million
21,554 Added 19.28%
133,328 $31 Million
Q4 2022

Feb 10, 2023
BUY
$187.24 - $242.74 $16.6 Million - $21.5 Million
88,549 Added 381.27%
111,774 $22.6 Million
Q3 2022

Nov 10, 2022
BUY
$177.23 - $227.44 $952,079 - $1.22 Million
5,372 Added 30.09%
23,225 $4.43 Million
Q2 2022

Aug 05, 2022
BUY
$181.58 - $368.0 $105,134 - $213,072
579 Added 3.35%
17,853 $3.29 Million
Q1 2022

May 12, 2022
BUY
$303.87 - $423.8 $3.04 Million - $4.25 Million
10,017 Added 138.03%
17,274 $6.04 Million
Q4 2021

Feb 10, 2022
SELL
$347.28 - $421.83 $8.45 Million - $10.3 Million
-24,325 Reduced 77.02%
7,257 $2.76 Million
Q3 2021

Nov 12, 2021
BUY
$405.61 - $524.84 $11.1 Million - $14.4 Million
27,489 Added 671.61%
31,582 $12.8 Million
Q2 2021

Aug 12, 2021
SELL
$372.84 - $481.5 $10.4 Million - $13.5 Million
-27,968 Reduced 87.23%
4,093 $1.94 Million
Q1 2021

May 13, 2021
BUY
$361.28 - $504.76 $8.88 Million - $12.4 Million
24,574 Added 328.22%
32,061 $12.3 Million
Q4 2020

Feb 16, 2021
SELL
$292.7 - $370.96 $23,708 - $30,047
-81 Reduced 1.07%
7,487 $2.77 Million
Q3 2020

Nov 12, 2020
BUY
$268.51 - $400.74 $430,690 - $642,786
1,604 Added 26.89%
7,568 $2.34 Million
Q2 2020

Aug 13, 2020
SELL
$256.46 - $373.01 $5.26 Million - $7.66 Million
-20,524 Reduced 77.48%
5,964 $2.21 Million
Q1 2020

May 13, 2020
BUY
$209.2 - $335.53 $3.85 Million - $6.17 Million
18,400 Added 227.5%
26,488 $7.23 Million
Q4 2019

Feb 12, 2020
BUY
$288.29 - $335.49 $266,668 - $310,328
925 Added 12.91%
8,088 $2.68 Million
Q3 2019

Nov 13, 2019
BUY
$266.84 - $378.23 $354,630 - $502,667
1,329 Added 22.78%
7,163 $2.18 Million
Q2 2019

Aug 07, 2019
SELL
$300.59 - $368.15 $428,340 - $524,613
-1,425 Reduced 19.63%
5,834 $2.15 Million
Q1 2019

May 08, 2019
BUY
$272.57 - $321.18 $470,183 - $554,035
1,725 Added 31.17%
7,259 $2.26 Million
Q4 2018

Feb 12, 2019
SELL
$272.46 - $366.54 $229,138 - $308,260
-841 Reduced 13.19%
5,534 $1.66 Million
Q3 2018

Nov 13, 2018
BUY
$279.04 - $367.06 $83,712 - $110,118
300 Added 4.94%
6,375 $2.34 Million
Q2 2018

Aug 02, 2018
SELL
$228.17 - $292.07 $228,170 - $292,070
-1,000 Reduced 14.13%
6,075 $1.7 Million
Q1 2018

May 14, 2018
SELL
$209.54 - $253.91 $167,632 - $203,128
-800 Reduced 10.16%
7,075 $1.67 Million
Q4 2017

Feb 09, 2018
BUY
$202.23 - $230.03 $101,115 - $115,015
500 Added 6.78%
7,875 $1.72 Million
Q3 2017

Nov 14, 2017
BUY
$172.3 - $213.93 $374,752 - $465,297
2,175 Added 41.83%
7,375 $1.47 Million
Q2 2017

Aug 14, 2017
BUY
N/A
5,200
5,200 $902,000

Others Institutions Holding ILMN

# of Institutions
901
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email